Asset Management One Co., Ltd. Biogen Inc. Transaction History

Asset Management One Co., Ltd.

$27.7 Billion
Q3 2024

A detailed history of Asset Management One Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 55,355 shares of BIIB stock, worth $8.25 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

55,355

Previous 55,031 0.59%

Holding current value

$8.25 Million

Previous $12.8 Million 15.89%

% of portfolio

0.04%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$189.07 - $236.8 $61,258 - $76,723	324 Added 0.59%	55,355 $10.7 Million
Q2 2024 Jul 18, 2024	SELL	$190.52 - $236.72 $739,027 - $918,236	-3,879 Reduced 6.58%	55,031 $12.8 Million
Q1 2024 May 02, 2024	SELL	$212.02 - $267.71 $497,610 - $628,315	-2,347 Reduced 3.83%	58,910 $12.7 Million
Q4 2023 Jan 24, 2024	SELL	$222.59 - $267.94 $531,099 - $639,304	-2,386 Reduced 3.75%	61,257 $15.9 Million
Q3 2023 Oct 19, 2023	BUY	$253.3 - $285.89 $959,500 - $1.08 Million	3,788 Added 6.33%	63,643 $16.4 Million
Q2 2023 Jul 31, 2023	BUY	$275.25 - $318.06 $412,324 - $476,453	1,498 Added 2.57%	59,855 $17 Million
Q1 2023 Apr 25, 2023	BUY	$256.56 - $292.34 $6,927 - $7,893	27 Added 0.05%	58,357 $16.2 Million
Q4 2022 Feb 06, 2023	SELL	$252.44 - $306.72 $759,844 - $923,227	-3,010 Reduced 4.91%	58,330 $16.2 Million
Q3 2022 Nov 04, 2022	SELL	$194.69 - $268.46 $238,884 - $329,400	-1,227 Reduced 1.96%	61,340 $16.4 Million
Q2 2022 Jul 29, 2022	SELL	$187.54 - $223.02 $82,517 - $98,128	-440 Reduced 0.7%	62,567 $12.8 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $704,160 - $887,204	-3,634 Reduced 5.45%	63,007 $13.3 Million
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $308,561 - $396,547	-1,378 Reduced 2.03%	66,641 $17.2 Million
Q3 2021 Nov 02, 2021	SELL	$282.99 - $369.05 $790,957 - $1.03 Million	-2,795 Reduced 3.95%	68,019 $19.2 Million
Q2 2021 Aug 03, 2021	SELL	$259.0 - $414.71 $374,514 - $599,670	-1,446 Reduced 2.0%	70,814 $24.5 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $1.92 Million - $2.25 Million	-7,905 Reduced 9.86%	72,260 $20.2 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $1.42 Million - $2.14 Million	-6,027 Reduced 6.99%	80,165 $19.5 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $1.96 Million - $2.26 Million	-7,391 Reduced 7.9%	86,192 $24.5 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $790,206 - $1.05 Million	-3,055 Reduced 3.16%	93,583 $25 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $4.02 Million - $5.1 Million	-14,944 Reduced 13.39%	96,638 $30.6 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $2.41 Million - $3.32 Million	-10,931 Reduced 8.92%	111,582 $33.1 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $2.46 Million - $2.76 Million	11,308 Added 10.17%	122,513 $28.5 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $1.76 Million - $1.94 Million	8,043 Added 7.8%	111,205 $26 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $50.1 Million - $78.3 Million	-230,965 Reduced 69.12%	103,162 $24.4 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $2.72 Million - $3.45 Million	-9,771 Reduced 2.84%	334,127 $100 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $955,081 - $1.25 Million	-3,254 Reduced 0.94%	343,898 $122 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $4.77 Million - $5.68 Million	-18,519 Reduced 5.06%	347,152 $101 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $2.28 Million - $3.23 Million	8,778 Added 2.46%	365,671 $100 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $1.75 Million - $1.95 Million	-5,673 Reduced 1.56%	356,893 $114 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $1.35 Million - $1.58 Million	-4,795 Reduced 1.31%	362,566 $113 Million
Q2 2017 Aug 14, 2017	BUY	N/A	367,361	367,361 $99.7 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.

Account

Asset Management One Co., Ltd. Biogen Inc. Transaction History